Related Experiment Video
Updated: Apr 24, 2026
09:54
Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
Published on: December 3, 2019
9.2K
Challenges in mucosal HIV vaccine development: lessons from non-human primate models
Iskra Tuero1, Marjorie Robert-Guroff2
1Vaccine Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. iskra.tuero@nih.gov.
Viruses
|September 9, 2014
Summary
Developing an effective HIV vaccine requires focusing on mucosal immunity. Non-human primate studies are crucial for advancing mucosal vaccine strategies and assessing immune responses for future human clinical trials.
Area of Science:
- Immunology
- Vaccinology
- Infectious Diseases
Background:
- An urgent need exists for an effective human immunodeficiency virus (HIV) vaccine to combat the global AIDS pandemic.
- While previous trials showed modest protection, new strategies are essential for significant advances in HIV vaccine development.
- HIV transmission predominantly occurs at mucosal surfaces, highlighting the critical need for mucosal immunity development.
Purpose of the Study:
- To review the role of non-human primate (NHP) studies in advancing the development of mucosal HIV vaccines.
- To highlight how NHP models inform strategies for targeting mucosal inductive sites and assessing mucosal immune responses.
- To underscore the importance of NHP research in guiding the design and evaluation of future HIV mucosal vaccine clinical trials.
Main Methods:
- Review of pre-clinical studies involving non-human primate models for HIV vaccine development.
- Analysis of methodologies for collecting and assessing mucosal samples in NHP studies.
- Examination of immune correlates of protective immunity identified in NHP research.
Main Results:
- NHP studies have been instrumental in evaluating candidate mucosal vaccine approaches.
- Methodologies for mucosal sample analysis and assessment have been refined through NHP research.
- NHP models have provided insights into immune correlates of protection relevant to mucosal immunity.
Conclusions:
- Non-human primate studies offer critical insights for designing effective HIV vaccine strategies targeting mucosal immunity.
- Further research in NHP models is essential for optimizing the assessment of mucosal immune responses.
- Knowledge from NHP studies will significantly inform the design and evaluation of human clinical trials for mucosal HIV vaccines.
